Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Platt

Showing results (461-470 of 505) with videos related to

Pageof 51
Sort By:
Pharmacological Reviews|February 25, 2026
Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipidsMichael Spedding, Johannes Aerts, Steve Alexander, et al.
Environmental Science & Technology|January 15, 2016
Characterization of Gas-Phase Organics Using Proton Transfer Reaction Time-of-Flight Mass Spectrometry: Cooking EmissionsFelix Klein, Stephen M Platt, Naomi J Farren, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2019
Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cellsMelissa Bedard, Dilip Shrestha, David A Priestman, et al.
Trials|January 23, 2021
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasiaT Fields, M Patterson, T Bremova-Ertl, et al.
Cancer Cell|November 15, 2017
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation FrequencyCarolyn D Hurst, Olivia Alder, Fiona M Platt, et al.
International Journal of Retina and Vitreous|February 2, 2023
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degenerationJoseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, et al.
Cancer Immunology Research|January 21, 2015
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cellsMatthew J Frigault, Jihyun Lee, Maria Ciocca Basil, et al.
Nature|August 6, 2013
Vesicular and non-vesicular transport feed distinct glycosylation pathways in the GolgiGiovanni D'Angelo, Takefumi Uemura, Chia-Chen Chuang, et al.
Pageof 51

Showing results (461-470 of 505) with videos related to

Sort By:
Pageof 51
Pharmacological Reviews|February 25, 2026
Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipidsMichael Spedding, Johannes Aerts, Steve Alexander, et al.
Environmental Science & Technology|January 15, 2016
Characterization of Gas-Phase Organics Using Proton Transfer Reaction Time-of-Flight Mass Spectrometry: Cooking EmissionsFelix Klein, Stephen M Platt, Naomi J Farren, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
Science Translational Medicine|September 9, 2016
Heat shock protein-based therapy as a potential candidate for treating the sphingolipidosesThomas Kirkegaard, James Gray, David A Priestman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2019
Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cellsMelissa Bedard, Dilip Shrestha, David A Priestman, et al.
Trials|January 23, 2021
A master protocol to investigate a novel therapy acetyl-L-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasiaT Fields, M Patterson, T Bremova-Ertl, et al.
Cancer Cell|November 15, 2017
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation FrequencyCarolyn D Hurst, Olivia Alder, Fiona M Platt, et al.
International Journal of Retina and Vitreous|February 2, 2023
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degenerationJoseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, et al.
Cancer Immunology Research|January 21, 2015
Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cellsMatthew J Frigault, Jihyun Lee, Maria Ciocca Basil, et al.
Nature|August 6, 2013
Vesicular and non-vesicular transport feed distinct glycosylation pathways in the GolgiGiovanni D'Angelo, Takefumi Uemura, Chia-Chen Chuang, et al.
Pageof 51